Phase II trial of irinotecan base regimen of bevacizumab for metastatic colorectal cancer progressed on oxaliplatin base regimen of bevacizumab
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Interventions: Bevacizumab and irrinotecan based chemotherapy (q2w FOLFIRI, q3w XELIRI, q3w/q4w IRIS) Primary outcome(s): Progression free survival Study Design: Single arm Non-randomized
创建时间：
2012-12-15
